Precision’s Carolyn Morgan Profiled in STAT News
Carolyn Morgan, precisioneffect’s president, is profiled in a new article featured in STAT News.
New Q&A with PHE’s Amitabh Chandra in STAT News
Precision Health Economics’ Scientific Advisor Amitabh Chandra is interviewed on the subject of precision medicine pricing, in a new Q&A for STAT News.
Briefing: How Health Systems Will Manage Biosimilars: Implications for Manufacturers
Precision for Value’s Jeremy Schafer discusses managing biosimilars and the implications for health systems in a new article for Biosimilars Development.
Briefing: 3 Advances Driving Oncology Clinical Trial Success
Precision subject matter expert Pat Devitt examines the 3 advances driving oncology clinical trial success in a special editorial for STAT News.
Tomas Philipson Participates in AEI Panel on Pricing of Specialty Drugs
On Monday, September 12th, 2016 at AEI, health policy experts representing practitioners and industry discussed the issue of high drug prices.
On the panel, Precision Health Economics’ Tomas Philipson cast doubt on the claim that research and development determine pricing, arguing that in reality causality runs in the opposite direction. He noted potential flaws in value-based pricing and a one-size-fits-all-approach to global drug development and argued for more robust credit markets in health care.